Target intelligence / Profile preview

Multiple non-specific protein surfaces

Molecular classification
Other
01

Overview

Multiple non-specific protein surfaces refers to the collective array of protein regions that engage in low-affinity, non-selective interactions with small molecules or biologics. These interactions are typically driven by general physicochemical properties such as lipophilicity and charge rather than the specific structural complementarity found in traditional drug-target binding sites (Baell & Walters, 2014). In drug discovery, high affinity for these non-specific surfaces is viewed as a significant liability, as it often correlates with high plasma protein binding and an increased risk of off-target toxicity (Di & Kerns, 2016). Compounds that interact broadly with these surfaces are frequently classified as Pan-Assay Interference Compounds (PAINS) or promiscuous binders, which can confound experimental results by inhibiting enzymes through non-specific mechanisms like aggregation (McGovern et al., 2002). Furthermore, extensive non-specific binding can sequester a drug, reducing the free concentration available to interact with its intended therapeutic target. Consequently, characterizing and minimizing these interactions is a critical component of lead optimization to ensure a favorable therapeutic index and predictable pharmacokinetics (Sasseville, 2004).

Other names
Non-specific protein binding sitesPromiscuous binding surfacesOff-target protein surfacesNon-selective protein surfaces
02

Mechanism of action

Non-specific adsorption via hydrophobic effects, van der Waals forces, and electrostatic interactions

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Off-target toxicityHigh plasma protein bindingAssay interference (PAINS)Reduced volume of distributionPoor bioavailability

Beyond the preview

Go deeper on Multiple non-specific protein surfaces.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multiple non-specific protein surfaces.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call